InvestorsHub Logo

MomsSpaghetti

01/11/21 4:59 PM

#2472 RE: GRODT014 #2466

A Study to Assess 18-Methoxycoronaridine

https://www.clinicaltrials.gov/ct2/show/NCT04292197?lead=Mind+Medicine%2C+Inc.&lead_ex=Y&draw=2&rank=1

Go to sections
Study Type : Interventional (Clinical Trial)
Estimated Enrollment : 77 participants
Allocation: Randomized
Intervention Model: Sequential Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Treatment
Official Title: A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Single/Multiple Day Dose Study to Assess the Safety, Tolerability, and Pharmacokinetics of 18- Methoxycoronaridine Administered Orally to Normal Healthy Volunteers
Actual Study Start Date : April 14, 2020
Estimated Primary Completion Date : March 30, 2021
Estimated Study Completion Date : April 30, 2021